Board of Directors

Born 1955. Dual citizen of Portugal and the United States of America. Chairman of the Board since 2020, member of the Board of Directors since 2019. Independent of the company and significant shareholders.

Education:Bachelor of Business Administration degree in Accounting from the Catholic University of Brazil. Owner/President Management program in General Management at Harvard Business School.

Experience:Mr. Calado has, among others, served as a member of the Board of Directors of Aveleda S.A. and OutSystems S.A. He has been President of iMAX Diagnostic Imaging Business Unit, Vice President of Hovione S.A., Vice President and CFO of Hovione S.A. Additionally, Mr. Calado has held various positions at PepsiCo, Inc. including Vice President and CFO of PepsiCo Foods International.

Other current positions of trust:Mr. Calado is the President of Gamcal LLC, Chairman of the Board of Directors of Wygroup, S.A, Chairman of the Supervisory Board of OutSystems S.A. and a member of the Board of Directors of HNI Corporation.

Holdings in the company:39,794 shares and 380,000 stock options, entitling to same amount of shares in the company.

Born 1957. Danish citizen. Member of the Board of Directors since 2019. Independent of the company and significant shareholders.

Education:Bachelor of Science degree in biochemical engineering from the Danish Technical University.

Experience:Mr. Laustsen has, among others, served as Chief Manufacturing Officer of Symphogen A/S, Chief Science Officer and member of the Board of Directors of CMC Biologics A/S (now AGC Biologics A/S), and CEO of CMC Biologics A/S.

Other current positions of trust:Mr. Laustsen is the co-founder and CEO of Bactolife ApS and member of the Board of Directors of Synklino ApS.

Holdings in the company:12,181 shares and 300,000 stock options, entitling to same amount of shares in the company.

Born 1971. Finnish citizen. Member of the Board of Directors since 2015, CFO and a member of the Management Team since 2018. Not independent of the company nor significant shareholders.

Education:
Bachelor of Science degree in economics from Hanken School of Economics in Helsinki.

Experience:
Mr. Hæggström has more than 20 years’ experience within finance and investing. Prior roles include senior positions at Alfred Berg, BNP Paribas, Nordea and SEB.

Other current positions of trust:
Mr. Hæggström is CFO and a member of the Management Team of Nanoform.

Holdings in the company:
701,135 shares and 400,000 stock options, entitling to same amount of shares in the company.

Born 1959. US and Irish citizen. Member of the Board of Directors since 2021. Independent of the company and significant shareholders.

Education:
Master of Business Administration from Fairleigh Dickinson University (US) and Bachelor of Science from Montclair State University (US).

Experience:
Ms. Thoma has, among others, served as President and CEO of SPI Pharma Inc, COO and President Microbial Control of Lonza AG and various leadership positions in the Pharmaceutical Ingredients business of BASF Corp.

Other current positions of trust:
Ms. Thoma serves as independent director on the boards of ANI Pharmaceuticals Inc., Avid Bioservices Inc., and Pharmthen Global BV. Previously Jeanne served on the board of Vectura Group Plc.

Holdings in the company:
12,181 shares 38 630 stock options, entitling to same amount of shares in the company.